Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 19 studies | 24% ± 6% | |
endothelial cell | 14 studies | 28% ± 14% | |
memory B cell | 13 studies | 21% ± 4% | |
macrophage | 11 studies | 32% ± 16% | |
astrocyte | 10 studies | 29% ± 14% | |
naive B cell | 9 studies | 19% ± 2% | |
microglial cell | 9 studies | 29% ± 10% | |
oligodendrocyte | 9 studies | 29% ± 10% | |
oligodendrocyte precursor cell | 9 studies | 30% ± 15% | |
glutamatergic neuron | 8 studies | 38% ± 27% | |
mast cell | 7 studies | 25% ± 5% | |
adipocyte | 7 studies | 29% ± 7% | |
fibroblast | 7 studies | 24% ± 14% | |
myeloid cell | 6 studies | 24% ± 7% | |
dendritic cell | 6 studies | 23% ± 3% | |
interneuron | 5 studies | 38% ± 23% | |
epithelial cell | 5 studies | 30% ± 16% | |
GABAergic neuron | 5 studies | 45% ± 21% | |
monocyte | 5 studies | 24% ± 6% | |
pericyte | 5 studies | 24% ± 9% | |
smooth muscle cell | 5 studies | 18% ± 2% | |
neuron | 4 studies | 35% ± 16% | |
precursor B cell | 3 studies | 18% ± 3% | |
CD16-negative, CD56-bright natural killer cell, human | 3 studies | 16% ± 1% | |
alveolar macrophage | 3 studies | 29% ± 9% | |
endothelial cell of lymphatic vessel | 3 studies | 25% ± 5% | |
lymphocyte | 3 studies | 27% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2770.24 | 2639 / 2642 | 100% | 21.88 | 704 / 705 |
esophagus | 100% | 2479.17 | 1444 / 1445 | 99% | 15.15 | 182 / 183 |
lung | 100% | 3452.85 | 578 / 578 | 99% | 12.02 | 1144 / 1155 |
thymus | 100% | 3448.49 | 653 / 653 | 98% | 13.62 | 595 / 605 |
prostate | 100% | 3192.24 | 245 / 245 | 98% | 19.39 | 493 / 502 |
pancreas | 100% | 3792.59 | 328 / 328 | 98% | 10.16 | 174 / 178 |
breast | 100% | 3307.45 | 459 / 459 | 97% | 13.25 | 1083 / 1118 |
stomach | 100% | 2159.53 | 359 / 359 | 96% | 10.39 | 274 / 286 |
kidney | 100% | 2122.54 | 89 / 89 | 95% | 11.76 | 858 / 901 |
skin | 100% | 3250.22 | 1809 / 1809 | 95% | 16.32 | 449 / 472 |
intestine | 100% | 2790.81 | 966 / 966 | 95% | 9.00 | 500 / 527 |
adrenal gland | 100% | 2851.60 | 258 / 258 | 93% | 11.30 | 215 / 230 |
uterus | 100% | 3283.36 | 170 / 170 | 92% | 8.25 | 423 / 459 |
bladder | 100% | 2582.19 | 21 / 21 | 92% | 7.97 | 462 / 504 |
ovary | 100% | 3113.33 | 180 / 180 | 92% | 6.97 | 394 / 430 |
liver | 100% | 1580.57 | 226 / 226 | 77% | 5.52 | 311 / 406 |
adipose | 100% | 3560.32 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 4819.99 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2847.34 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1797.51 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 1748.41 | 842 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 14.70 | 28 / 29 |
tonsil | 0% | 0 | 0 / 0 | 96% | 11.71 | 43 / 45 |
peripheral blood | 86% | 2207.11 | 799 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 78% | 7.35 | 62 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0090382 | Biological process | phagosome maturation |
GO_0006898 | Biological process | receptor-mediated endocytosis |
GO_0030593 | Biological process | neutrophil chemotaxis |
GO_0032288 | Biological process | myelin assembly |
GO_1903100 | Biological process | 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process |
GO_0006612 | Biological process | protein targeting to membrane |
GO_0032438 | Biological process | melanosome organization |
GO_1904562 | Biological process | phosphatidylinositol 5-phosphate metabolic process |
GO_1903426 | Biological process | regulation of reactive oxygen species biosynthetic process |
GO_0042147 | Biological process | retrograde transport, endosome to Golgi |
GO_0036092 | Biological process | phosphatidylinositol-3-phosphate biosynthetic process |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0090385 | Biological process | phagosome-lysosome fusion |
GO_0034504 | Biological process | protein localization to nucleus |
GO_2000785 | Biological process | regulation of autophagosome assembly |
GO_0019065 | Biological process | receptor-mediated endocytosis of virus by host cell |
GO_0019886 | Biological process | antigen processing and presentation of exogenous peptide antigen via MHC class II |
GO_0036289 | Biological process | peptidyl-serine autophosphorylation |
GO_0006661 | Biological process | phosphatidylinositol biosynthetic process |
GO_0031902 | Cellular component | late endosome membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0012506 | Cellular component | vesicle membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0045121 | Cellular component | membrane raft |
GO_0031901 | Cellular component | early endosome membrane |
GO_0005911 | Cellular component | cell-cell junction |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005829 | Cellular component | cytosol |
GO_0030670 | Cellular component | phagocytic vesicle membrane |
GO_0010008 | Cellular component | endosome membrane |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0016308 | Molecular function | 1-phosphatidylinositol-4-phosphate 5-kinase activity |
GO_0000285 | Molecular function | 1-phosphatidylinositol-3-phosphate 5-kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0052810 | Molecular function | 1-phosphatidylinositol-5-kinase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
GO_0043813 | Molecular function | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity |
Gene name | PIKFYVE |
Protein name | 1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (Serine-protein kinase PIKFYVE) (EC 2.7.11.1) Alternative protein PIKFYVE Phosphoinositide kinase, FYVE-type zinc finger containing |
Synonyms | KIAA0981 PIP5K3 |
Description | FUNCTION: Dual specificity kinase implicated in myriad essential cellular processes such as maintenance of endomembrane homeostasis, and endocytic-vacuolar pathway, lysosomal trafficking, nuclear transport, stress- or hormone-induced signaling and cell cycle progression . The PI(3,5)P2 regulatory complex regulates both the synthesis and turnover of phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2). Sole enzyme to catalyze the phosphorylation of phosphatidylinositol 3-phosphate on the fifth hydroxyl of the myo-inositol ring, to form (PtdIns(3,5)P2) . Also catalyzes the phosphorylation of phosphatidylinositol on the fifth hydroxyl of the myo-inositol ring, to form phosphatidylinositol 5-phosphate (PtdIns(5)P) . Has serine-protein kinase activity and is able to autophosphorylate and transphosphorylate. Autophosphorylation inhibits its own phosphatidylinositol 3-phosphate 5-kinase activity, stimulates FIG4 lipid phosphatase activity and down-regulates lipid product formation . Involved in key endosome operations such as fission and fusion in the course of endosomal cargo transport . Required for the maturation of early into late endosomes, phagosomes and lysosomes . Regulates vacuole maturation and nutrient recovery following engulfment of macromolecules, initiates the redistribution of accumulated lysosomal contents back into the endosome network . Critical regulator of the morphology, degradative activity, and protein turnover of the endolysosomal system in macrophages and platelets (By similarity). In neutrophils, critical to perform chemotaxis, generate ROS, and undertake phagosome fusion with lysosomes . Plays a key role in the processing and presentation of antigens by major histocompatibility complex class II (MHC class II) mediated by CTSS . Regulates melanosome biogenesis by controlling the delivery of proteins from the endosomal compartment to the melanosome . Essential for systemic glucose homeostasis, mediates insulin-induced signals for endosome/actin remodeling in the course of GLUT4 translocation/glucose uptake activation (By similarity). Supports microtubule-based endosome-to-trans-Golgi network cargo transport, through association with SPAG9 and RABEPK (By similarity). Mediates EGFR trafficking to the nucleus . .; FUNCTION: (Microbial infection) Required for cell entry of coronaviruses SARS-CoV and SARS-CoV-2, as well as human coronavirus EMC (HCoV-EMC) by endocytosis. . |
Accessions | ENST00000452564.1 L8E9N1 ENST00000308862.10 [Q9Y2I7-3] C9JL08 F8WEZ0 ENST00000392202.7 [Q9Y2I7-2] ENST00000443896.5 ENST00000264380.9 [Q9Y2I7-1] ENST00000407449.5 [Q9Y2I7-4] E9PDH4 Q9Y2I7 ENST00000422495.5 |